Raludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
Encouraging overall response rate of 46% and disease control rate of 98% with a median duration of response of 11.2 months seen with raludotatug deruxtecan in heavily... Read more.
Datopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab showed a confirmed objective response rate of 79% Two ongoing phase 3 trials are evaluating... Read more.
Detailed Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2023
– Cabozantinib compared with placebo reduced the risk of disease progression or death in patients with pancreatic NET and in patients with extra-pancreatic NET... Read more.
Faraday Future to Deliver FF 91 2.0 Futurist Alliance to World Champion Race Car Driver Justin Bell on October 24
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a California-based... Read more.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Enviva Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EVA
NEW YORK–(BUSINESS WIRE)–$EVA #EVA—WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Enviva Inc. (NYSE:... Read more.
SME Launches Training and Electric Vehicle Certification to Address High and Unmet Demand for Electrification Skills
Designed for Positions Working with Electric Vehicles and E-Mobility SOUTHFIELD, Mich.–(BUSINESS WIRE)–SME, the nonprofit committed to accelerating new... Read more.
AeroDef Manufacturing 2023 Exhibitor Preview: Aerospace and Defense Global Suppliers, Distributors and Equipment Builders to Demonstrate Innovative Technologies and Solutions for Sector Manufacturers
LONG BEACH, Calif.–(BUSINESS WIRE)–AeroDef Manufacturing 2023, an SME event produced in partnership with original equipment manufacturers (OEMs), is... Read more.
Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation
SAN DIEGO–(BUSINESS WIRE)–Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic Holding, Inc. (NASDAQ:... Read more.
KVUE Shareholder Update: Johnson Fistel Encourages Kenvue Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline
SAN DIEGO–(BUSINESS WIRE)–Johnson Fistel, LLP notifies investors of Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE) a securities class action... Read more.
SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Startek to Capital Square Partners
SAN DIEGO–(BUSINESS WIRE)–Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Startek, Inc.... Read more.